Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Waldmann

Showing results (61-70 of 2,585) with videos related to

Pageof 259
Sort By:
Molecular and Cellular Endocrinology|February 20, 2017
JAK/STAT pathway directed therapy of T-cell leukemia/lymphoma: Inspired by functional and structural genomicsThomas A Waldmann
Clinical Immunology and Immunopathology|July 1, 1986
Immunodeficiency: immunoregulation and immunogeneticsT A Waldmann
Science (New York, N.Y.)|June 21, 1991
Monoclonal antibodies in diagnosis and therapyT A Waldmann
Immunology Today|June 1, 1993
The IL-2/IL-2 receptor system: a target for rational immune interventionT A Waldmann
Annual Review of Immunology|January 1, 1992
Immune receptors: targets for therapy of leukemia/lymphoma, autoimmune diseases and for the prevention of allograft rejectionT A Waldmann
The Journal of Investigative Dermatology. Symposium Proceedings|December 12, 2013
The biology of IL-15: implications for cancer therapy and the treatment of autoimmune disordersThomas A Waldmann
Cellular Immunology|April 15, 1986
The interleukin-2 receptor on malignant cells: a target for diagnosis and therapyT A Waldmann
Clinical Immunology and Immunopathology|November 1, 1991
Lymphokine receptor-directed therapy: a model for immune intervention in leukemia, autoimmunity, and immunodeficiencyT A Waldmann
Annals of Allergy|August 1, 1977
The 1977 Bela Schick Memorial Lecture: disorders of suppressor cells in the pathogenesis of immunodeficiency, autoimmune and allergic diseases: human disease associated with disorders of an immunological breaking systemT A Waldmann
Environmental Health Perspectives|November 1, 1987
The role of the multichain IL-2 receptor complex in the control of normal and malignant T-cell proliferationT A Waldmann
Pageof 259

Showing results (61-70 of 2,585) with videos related to

Sort By:
Pageof 259
Molecular and Cellular Endocrinology|February 20, 2017
JAK/STAT pathway directed therapy of T-cell leukemia/lymphoma: Inspired by functional and structural genomicsThomas A Waldmann
Clinical Immunology and Immunopathology|July 1, 1986
Immunodeficiency: immunoregulation and immunogeneticsT A Waldmann
Science (New York, N.Y.)|June 21, 1991
Monoclonal antibodies in diagnosis and therapyT A Waldmann
Immunology Today|June 1, 1993
The IL-2/IL-2 receptor system: a target for rational immune interventionT A Waldmann
Annual Review of Immunology|January 1, 1992
Immune receptors: targets for therapy of leukemia/lymphoma, autoimmune diseases and for the prevention of allograft rejectionT A Waldmann
The Journal of Investigative Dermatology. Symposium Proceedings|December 12, 2013
The biology of IL-15: implications for cancer therapy and the treatment of autoimmune disordersThomas A Waldmann
Cellular Immunology|April 15, 1986
The interleukin-2 receptor on malignant cells: a target for diagnosis and therapyT A Waldmann
Clinical Immunology and Immunopathology|November 1, 1991
Lymphokine receptor-directed therapy: a model for immune intervention in leukemia, autoimmunity, and immunodeficiencyT A Waldmann
Annals of Allergy|August 1, 1977
The 1977 Bela Schick Memorial Lecture: disorders of suppressor cells in the pathogenesis of immunodeficiency, autoimmune and allergic diseases: human disease associated with disorders of an immunological breaking systemT A Waldmann
Environmental Health Perspectives|November 1, 1987
The role of the multichain IL-2 receptor complex in the control of normal and malignant T-cell proliferationT A Waldmann
Pageof 259